Therefore, we examined whether the knockdown of RPIA can also reduce the levels of phosphorylated ERK1/2 (p-ERK1/2) in shRPIA#1 and shRPIA#2 A549 lung cancer cells. The gene discussed is MAPK3; the disease is lung cancer.